Cite
Wang H, Sun J, Zhang B, et al. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells. Clin Transl Med. 2021;11(10):e610doi: 10.1002/ctm2.610.
Wang, H., Sun, J., Zhang, B., Zhao, D., Tong, H., Wu, H., Li, X., Luo, Y., Dong, D., Yao, Y., McDonald, T., Stein, A. S., Al Malki, M. M., Pichiorri, F., Carlesso, N., Kuo, Y. H., Marcucci, G., Li, L., & Jin, J. (2021). Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells. Clinical and translational medicine, 11(10), e610. https://doi.org/10.1002/ctm2.610
Wang, Huafeng, et al. "Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells." Clinical and translational medicine vol. 11,10 (2021): e610. doi: https://doi.org/10.1002/ctm2.610
Wang H, Sun J, Zhang B, Zhao D, Tong H, Wu H, Li X, Luo Y, Dong D, Yao Y, McDonald T, Stein AS, Al Malki MM, Pichiorri F, Carlesso N, Kuo YH, Marcucci G, Li L, Jin J. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells. Clin Transl Med. 2021 Oct;11(10):e610. doi: 10.1002/ctm2.610. PMID: 34709739; PMCID: PMC8516361.
Copy
Download .nbib